{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T07:57:29Z","timestamp":1789804649719,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020884","name":"QIAGEN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020884","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ijid.2023.02.016","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T07:04:06Z","timestamp":1678172646000},"page":"S43-S46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"S1","title":["Programmatic management of tuberculosis preventive therapy: Past, present, future"],"prefix":"10.1016","volume":"130","author":[{"given":"Alberto","family":"Matteelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Lovatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Sforza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2023.02.016_bib0001","series-title":"Implementing the End TB Strategy: the essentials","year":"2015"},{"key":"10.1016\/j.ijid.2023.02.016_bib0002","year":"2018"},{"key":"10.1016\/j.ijid.2023.02.016_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2023.02.016_bib0004","series-title":"Global tuberculosis report 2022","year":"2022"},{"key":"10.1016\/j.ijid.2023.02.016_bib0005","series-title":"Global Tuberculosis Report 2022: TB prevention","year":"2022"},{"key":"10.1016\/j.ijid.2023.02.016_bib0006","series-title":"WHO guidelines on the management of latent tuberculosis infection","year":"2015"},{"key":"10.1016\/j.ijid.2023.02.016_bib0007","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1473-3099(03)00741-2","article-title":"Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection","volume":"3","author":"Tufariello","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2023.02.016_bib0008","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1093\/jac\/dkq374","article-title":"Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis","volume":"65","author":"De Steenwinkel","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2023.02.016_bib0009","first-page":"682","article-title":"The effect of antimicrobial therapy on the prognosis of primary tuberculosis in children","volume":"69","author":"Lincoln","year":"1954","journal-title":"Am Rev Tuberc"},{"key":"10.1016\/j.ijid.2023.02.016_bib0010","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/aje\/kwz172","article-title":"Seventy years of tuberculosis prevention: efficacy, effectiveness, toxicity, durability, and duration","volume":"188","author":"Salazar-Austin","year":"2019","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ijid.2023.02.016_bib0011","first-page":"297","article-title":"Preventive treatment in tuberculosis: a statement by the committee on therapy, American Thoracic Society","volume":"91","author":"Runyon","year":"1965","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ijid.2023.02.016_bib0012","series-title":"WHO consolidated guidelines on tuberculosis. Module 1: prevention \u2013 tuberculosis preventive treatment","year":"2020"},{"key":"10.1016\/j.ijid.2023.02.016_bib0013","series-title":"WHO consolidated guidelines on tuberculosis. Module 2: screening \u2013 systematic screening for tuberculosis disease","year":"2021"},{"key":"10.1016\/j.ijid.2023.02.016_bib0014","series-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","year":"2018"},{"key":"10.1016\/j.ijid.2023.02.016_bib0015","doi-asserted-by":"crossref","first-page":"823","DOI":"10.5588\/ijtld.21.0293","article-title":"TB preventive treatment in high- and intermediate-incidence countries: research needs for scale-up","volume":"25","author":"Oxlade","year":"2021","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2023.02.016_bib0016","series-title":"Rapid communication: TB antigen-based skin tests for the diagnosis of TB infection","year":"2022"},{"key":"10.1016\/j.ijid.2023.02.016_bib0017","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S1473-3099(20)30914-2","article-title":"Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial","volume":"21","author":"Scriba","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2023.02.016_bib0018","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijid.2019.11.023","article-title":"Preventive tuberculosis treatment effect on QuantiFERON TB-Gold in-tube testing in a high tuberculosis-endemic country: a clinical trial","volume":"91","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2023.02.016_bib0019","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/resp.13272","article-title":"Update on tuberculosis biomarkers: from correlates of risk, to correlates of active disease and of cure from disease","volume":"23","author":"Goletti","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.ijid.2023.02.016_bib0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12916-016-0589-3","article-title":"The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study","volume":"14","author":"Hermans","year":"2016","journal-title":"BMC Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223000620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971223000620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T16:35:23Z","timestamp":1746376523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971223000620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":20,"alternative-id":["S1201971223000620"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2023.02.016","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Programmatic management of tuberculosis preventive therapy: Past, present, future","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2023.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}